Skip to main content
. 2021 Jul 6;14(2):1071–1079. doi: 10.1159/000516760

Fig. 1.

Fig. 1

Complete response of metastatic disease in patient 1. a A 1.3-cm mass in the liver at the time of diagnosis (arrowhead). b Complete resolution of the lesion after neoadjuvant therapy with 12 weeks of paclitaxel and trastuzumab, followed by 1 year of trastuzumab monotherapy. c Left lower lobe mass (*) that progressed on multiple lines of therapy, prior to initiating trastuzumab deruxtecan. d Complete response in the lung after 1 year of trastuzumab deruxtecan.